Monopar Therapeutics (MNPR) Debt to Equity (2020)
Monopar Therapeutics (MNPR) has disclosed Debt to Equity for 1 consecutive years, with $0.01 as the latest value for Q3 2020.
Monopar Therapeutics (MNPR) has disclosed Debt to Equity for 1 consecutive years, with $0.01 as the latest value for Q3 2020.